Publication | Open Access
A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer’s disease
161
Citations
45
References
2015
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1